ABSTRACT
Objective To study the correlated factors of long-term survival after hepatectomy.Methods The preoperative and postoperative conditions of 94 patients with liver cancer survived over 10 years after hepatectomy were enrolled for reviewing analysis.Results The important correlated factors of postoperative long-term survival are the following:(1) Diameter of tumor≤ 5 cm(73.4 ％);peripheral liver cancer(70.2 ％).(2) Effective treatment for recurrence.(3) Long-term and regular treatment of antiliver fibrosis and anti-cancer after hepatectomy(mainly Chinese Medicine).(4)Enforcing follow-up survey.Conclusion Diameter of tumor≤5 cm,peripheral liver cancer patients,enforcing follow-up survey and Chinese Medicine treatment are important factors of achieve long-term survival after hepatectomy.
ABSTRACT
Objective To observe the effects of Shenhong (SH) combined with chemotherapeutic drugs on curative effect, symptoms improvement, and immunology function in metaphase or terminal cancer patients.Methods All 598 patients were divided into two groups. The control group had 205 patients treated with chemotherapeutic drugs. The SH-treated group had 393 patients treated with SH combined with chemotherapeutic drugs. Results Compared with control patients, the total remission was 42.0% in SH-treated patients. The improvement rates of pain, cough, debilitation, and anepithymia were 71.9%. The Karnofsky grade was increased by 27.0%. CD+3 and CD+4 were increased by 11.6% and 19.3%, but CD+8was decreased by 22.6% at the same time. The patients CD+4 / CD+8 was enhanced by 54.2%, while the NK cell activity and marophage phagocysis were significantly improved. The content of Ig G and Ig A were increased in the same group. Conclusion The curative effect of SH combined with chemotherapeutic drugs was higher than that of control group. The therapeutic effect of SH is explained by its potential regulation activity on immun system.